ID: ALA3975921

Max Phase: Preclinical

Molecular Formula: C12H8FNO2

Molecular Weight: 217.20

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(c1ccc(F)c(O)c1)c1ccccn1

Standard InChI:  InChI=1S/C12H8FNO2/c13-9-5-4-8(7-11(9)15)12(16)10-3-1-2-6-14-10/h1-7,15H

Standard InChI Key:  LNRJQPSMOUKTRE-UHFFFAOYSA-N

Associated Targets(Human)

17-beta-hydroxysteroid dehydrogenase 14 155 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 217.20Molecular Weight (Monoisotopic): 217.0539AlogP: 2.16#Rotatable Bonds: 2
Polar Surface Area: 50.19Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.76CX Basic pKa: 2.46CX LogP: 2.44CX LogD: 2.28
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.78Np Likeness Score: -0.90

References

1. Braun F, Bertoletti N, Möller G, Adamski J, Steinmetzer T, Salah M, Abdelsamie AS, van Koppen CJ, Heine A, Klebe G, Marchais-Oberwinkler S..  (2016)  First Structure-Activity Relationship of 17β-Hydroxysteroid Dehydrogenase Type 14 Nonsteroidal Inhibitors and Crystal Structures in Complex with the Enzyme.,  59  (23): [PMID:27933965] [10.1021/acs.jmedchem.6b01436]

Source